Sponsor Pipeline

Vanguard Research Group Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 4
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06923891 An Open-Label Study to Evaluate the Efficacy and Tolerability of Xanomeline/Trospium In… Schizophrenia Not Yet Recruiting
Disease Areas
Schizophrenia (1)
Get alerts when Vanguard Research Group's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free